Proteinuria in chronic kidney disease in cats - Prognostic marker or therapeutic target?

被引:0
作者
Elliott, Jonathan [1 ]
Syme, Harriet M. [1 ]
机构
[1] Univ London Royal Vet Coll, London NW1 0TU, England
关键词
D O I
10.1892/0891-6640(2006)20[1052:EPICKD]2.0.CO;2
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
引用
收藏
页码:1052 / 1053
页数:2
相关论文
共 50 条
[41]   Proteinuria versus albuminuria in chronic kidney disease [J].
Guh, Jinn-Yuh .
NEPHROLOGY, 2010, 15 :53-56
[42]   Chronic kidney disease in cats Response [J].
Lefebvre, Sandra L. ;
Lund, Elizabeth M. ;
Polzin, David J. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2014, 244 (07) :776-777
[43]   Chronic Kidney Disease in Dogs and Cats [J].
Bartges, Joseph W. .
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2012, 42 (04) :669-+
[44]   Chronic kidney disease in cats FOREWORD [J].
Cannon, Martha ;
Caney, Sarah .
IN PRACTICE, 2016, 38 :1-1
[45]   Managing chronic kidney disease in cats [J].
Maddison, Jill .
VETERINARY RECORD, 2009, 164 (21) :668-668
[46]   TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review [J].
Zixin, Ye ;
Lulu, Chen ;
Xiangchang, Zeng ;
Qing, Fang ;
Binjie, Zheng ;
Chunyang, Luo ;
Tai, Rao ;
Dongsheng, Ouyang .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[47]   Fluid overload as a therapeutic target for the preservative management of chronic kidney disease [J].
Palmer, Biff F. ;
Clegg, Deborah J. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (01) :22-28
[48]   Actin cytoskeleton alterations in podocytes: a therapeutic target for chronic kidney disease [J].
Susan J. Allison .
Nature Reviews Nephrology, 2015, 11 (7) :385-385
[49]   Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease [J].
Yujiro Kida ;
Bie Nga Tchao ;
Ikuyo Yamaguchi .
Pediatric Nephrology, 2014, 29 :333-342
[50]   Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease [J].
Malyszko, Jolanta ;
Malyszko, Jacek S. ;
Matuszkiewicz-Rowinska, Joanna .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (05) :407-421